Julie McMullen

Eisai Canada

At Eisai Canada, human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the Canadian pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Comments and posts by users on this site are not created or controlled by Eisai Canada and Eisai is not responsible for such content.